Deutsche Bank Aktiengesellschaft Has Lowered Expectations for CME Group (NASDAQ:CME) Stock Price

CME Group (NASDAQ:CME) had its price target cut by Deutsche Bank Aktiengesellschaft from $227.00 to $226.00 in a report published on Monday,Benzinga reports. They currently have a hold rating on the financial services provider’s stock.

Other analysts have also recently issued reports about the stock. Citigroup raised their target price on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a report on Thursday, October 24th. Redburn Atlantic lowered CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective for the company. in a research note on Tuesday, October 8th. Barclays boosted their target price on CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 24th. Bank of America increased their price target on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Finally, The Goldman Sachs Group boosted their price objective on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday, October 3rd. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $224.47.

CME Group Price Performance

NASDAQ CME opened at $223.42 on Monday. The firm has a market capitalization of $80.45 billion, a PE ratio of 23.49, a P/E/G ratio of 5.69 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. CME Group has a 12 month low of $190.70 and a 12 month high of $230.36. The company’s 50 day simple moving average is $222.44 and its 200 day simple moving average is $210.17.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the business earned $2.25 EPS. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. As a group, equities research analysts forecast that CME Group will post 10.23 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be paid a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.06%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Insider Activity at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The trade was a 12.01 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. The trade was a 5.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,621 shares of company stock valued at $3,441,063. 0.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the stock. Harbor Capital Advisors Inc. raised its position in shares of CME Group by 0.6% in the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock valued at $1,723,000 after purchasing an additional 45 shares during the period. CVA Family Office LLC grew its stake in CME Group by 11.8% in the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after buying an additional 46 shares during the last quarter. Lester Murray Antman dba SimplyRich raised its holdings in CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after acquiring an additional 50 shares during the period. Zions Bancorporation N.A. lifted its position in CME Group by 3.7% during the 3rd quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock worth $338,000 after acquiring an additional 54 shares during the last quarter. Finally, Quent Capital LLC boosted its holdings in CME Group by 10.2% during the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after acquiring an additional 55 shares during the period. 87.75% of the stock is owned by institutional investors.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.